Detalhe da pesquisa
1.
Safety and activity of pembrolizumab in patients with locally advanced or metastatic urothelial cancer (KEYNOTE-012): a non-randomised, open-label, phase 1b study.
Lancet Oncol
; 18(2): 212-220, 2017 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-28081914
2.
Pembrolizumab for patients with PD-L1-positive advanced gastric cancer (KEYNOTE-012): a multicentre, open-label, phase 1b trial.
Lancet Oncol
; 17(6): 717-726, 2016 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-27157491
3.
The Society for Immunotherapy of Cancer statement on best practices for multiplex immunohistochemistry (IHC) and immunofluorescence (IF) staining and validation.
J Immunother Cancer
; 8(1)2020 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-32414858
4.
Primary pituitary lymphoma: a histological, immunohistochemical, and ultrastructural study with literature review.
Endocr Pathol
; 20(1): 46-9, 2009.
Artigo
em Inglês
| MEDLINE | ID: mdl-19229666
5.
Clinical Utility of the Combined Positive Score for Programmed Death Ligand-1 Expression and the Approval of Pembrolizumab for Treatment of Gastric Cancer.
Arch Pathol Lab Med
; 143(3): 330-337, 2019 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-30028179
6.
Inhibition of poly(adenosine diphosphate-ribose) polymerase attenuates ventilator-induced lung injury.
Anesthesiology
; 108(2): 261-8, 2008 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-18212571
7.
Rectal gastrointestinal stromal tumor mimicking a primary prostatic lesion.
Can J Urol
; 15(3): 4112-4, 2008 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-18570720
8.
Use of the 22C3 anti-programmed death-ligand 1 antibody to determine programmed death-ligand 1 expression in cytology samples obtained from non-small cell lung cancer patients.
Cancer Cytopathol
; 126(4): 264-274, 2018 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-29411536
9.
Parathyroid chief cell adenoma associated with massive chronic parathyroiditis in a woman with hyperparathyroidism.
Endocr Pathol
; 18(1): 42-5, 2007.
Artigo
em Inglês
| MEDLINE | ID: mdl-17652800
10.
Use of the 22C3 anti-PD-L1 antibody to determine PD-L1 expression in multiple automated immunohistochemistry platforms.
PLoS One
; 12(8): e0183023, 2017.
Artigo
em Inglês
| MEDLINE | ID: mdl-28797130
11.
Correction: Use of the 22C3 anti-PD-L1 antibody to determine PD-L1 expression in multiple automated immunohistochemistry platforms.
PLoS One
; 12(10): e0186537, 2017.
Artigo
em Inglês
| MEDLINE | ID: mdl-29028832
12.
PD-L2 Expression in Human Tumors: Relevance to Anti-PD-1 Therapy in Cancer.
Clin Cancer Res
; 23(12): 3158-3167, 2017 Jun 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-28619999
13.
Flow cytometry in the differential diagnosis of lymphocyte-rich thymoma from precursor T-cell acute lymphoblastic leukemia/lymphoblastic lymphoma.
Am J Clin Pathol
; 121(2): 268-74, 2004 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-14983942
14.
Immunophenotypic analysis of anaplastic large cell lymphoma by flow cytometry.
Am J Clin Pathol
; 119(2): 205-12, 2003 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-12579990